Literature DB >> 16228823

Total mesorectal excision for rectal cancer: difference in outcome for low and high rectal cancer.

Arne E Faerden1, Nazir Naimy, Pål Wiik, Ola Reiertsen, Seyoum Weyessa, Sigurd Trønnes, Solveig Norheim Andersen, Arne Bakka.   

Abstract

PURPOSE: This prospective study was designed to assess the outcome through the first five years after the introduction of total mesorectal excision in 1993 in a Norwegian central hospital, with special regard to the difference between low (< or =6 cm from anal verge) and high (>6 cm) rectal cancers.
METHODS: A total of 140 patients (81 males; median age, 64 (range, 29-87) years) underwent surgery for rectal cancer under curative intention.
RESULTS: Local recurrence rates were 8 of 44 (18 percent) for the low cancers and 5 of 96 (5 percent) for the high, a statistically significant difference (P = 0.0014). Corresponding numbers when the R1 resections are excluded were 5 of 36 (13 percent) for the low and 4 of 92 (4 percent) for the high cancers (P = 0.002). The five-year survival after R0 resections of cancers <6 cm was significantly reduced compared with those >6 cm. The five-year overall survival for the whole material was 72 percent.
CONCLUSIONS: Surgery alone for rectal cancer can achieve overall good results, with five-year overall survival of 72 percent. The prognosis of the cancers of the lower rectum seems to be inherently different from the tumors of the higher level, both concerning local recurrence and five-year survival, suggesting different biologic behavior of the two cancers.

Entities:  

Mesh:

Year:  2005        PMID: 16228823     DOI: 10.1007/s10350-005-0191-9

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  16 in total

Review 1.  The total mesorectal excision specimen for rectal cancer: a review of its pathological assessment.

Authors:  Jeremy R Parfitt; David K Driman
Journal:  J Clin Pathol       Date:  2006-10-17       Impact factor: 3.411

2.  Transanal total mesorectal excision (TaTME): single-centre early experience in a selected population.

Authors:  Michele De Rosa; Fabio Rondelli; Marcello Boni; Fabio Ermili; Walter Bugiantella; Lorenzo Mariani; Graziano Ceccarelli; Antonio Giuliani
Journal:  Updates Surg       Date:  2018-11-08

3.  Preoperative FOLFOX in resectable locally advanced rectal cancer can be a safe and promising strategy: the R-NAC-01 study.

Authors:  Nobuki Ichikawa; Shigenori Homma; Tohru Funakoshi; Masahiro Hattori; Masanori Sato; You Kamiizumi; Kazuyoshi Omori; Masaru Nomura; Ryoichi Yokota; Masahiko Koike; Hirofumi Kon; Keisa Takeda; Hiroyuki Ishizu; Kunihiro Hirose; Daisuke Kuraya; Takahisa Ishikawa; Ryohei Murata; Hiroaki Iijima; Futoshi Kawamata; Tadashi Yoshida; Yosuke Ohno; Nozomi Minagawa; Norihiko Takahashi; Akinobu Taketomi
Journal:  Surg Today       Date:  2019-03-05       Impact factor: 2.549

4.  Selective use of preoperative chemoradiotherapy for T3 rectal cancer can be justified: analysis of local recurrence.

Authors:  Se-Jin Baek; Seon-Hahn Kim; Jung-Myun Kwak; Jae-Sung Cho; Jae-Won Shin; Azali Hafiz Yafee Amar; Jin Kim
Journal:  World J Surg       Date:  2013-01       Impact factor: 3.352

5.  Transanal total mesorectal excision in the prone jackknife position without being conscious of the size of prostatic enlargement for lower rectal cancer.

Authors:  Dai Uematsu; Gaku Akiyama; Takeiko Sugihara; Akiko Magishi; Minoru Imai; Kojiro Ono
Journal:  Int Cancer Conf J       Date:  2020-04-20

6.  Changes in the renin angiotensin system during the development of colorectal cancer liver metastases.

Authors:  Jaclyn H Neo; Eleanor I Ager; Peter W Angus; Jin Zhu; Chandana B Herath; Christopher Christophi
Journal:  BMC Cancer       Date:  2010-04-10       Impact factor: 4.430

7.  Laparoscopic resection of extraperitoneal rectal cancer: a comparative analysis with open resection.

Authors:  In Ja Park; Gyu-Seog Choi; Kyung-Hoon Lim; Byung-Mo Kang; Soo-Han Jun
Journal:  Surg Endosc       Date:  2009-01-01       Impact factor: 4.584

8.  Transanal minimally invasive surgery for total mesorectal excision (TAMIS-TME): results and experience with the first 20 patients undergoing curative-intent rectal cancer surgery at a single institution.

Authors:  S Atallah; B Martin-Perez; M Albert; T deBeche-Adams; G Nassif; L Hunter; S Larach
Journal:  Tech Coloproctol       Date:  2013-11-23       Impact factor: 3.781

9.  MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of colorectal cancer.

Authors:  Chibo Liu; Chunqin Pan; Jianmin Shen; Haibao Wang; Liang Yong
Journal:  Int J Med Sci       Date:  2011-01-03       Impact factor: 3.738

10.  Risk factors of circumferential resection margin involvement in the patients with extraperitoneal rectal cancer.

Authors:  Sung Jin Oh; Jin Yong Shin
Journal:  J Korean Surg Soc       Date:  2012-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.